TipRanks
Go Ultimate55% OFF

CellSeed Inc. (7776) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Cls2901cOsteoarthritis Of The KneePhase IIIRecruitingA Phase III Study of CLS2901C in Patients With Osteoarthritis of the KneeAug 08, 2024
Cls2702c/Cls2702dSuperficial Esophageal CancerPhase IIITerminatedA Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk GroupDec 28, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does CellSeed Inc. (JP:7776) have in its pipeline
CellSeed Inc. JP:7776 is currently developing the following drugs: Cls2901c, Cls2702c/Cls2702d. These drug candidates are in various stages of clinical development as the company works toward FDA approval.